echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Merck announced the completion of the spin-off of Ogalon

    Merck announced the completion of the spin-off of Ogalon

    • Last Update: 2021-07-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Merck (NYSE: MRK, Merck is the corporate name of Merck & Co.
    , Kenilworth, New Jersey) announced today that the company has completed the spin-off of Organon
    .

    Today is an important milestone for Merck and Ogalon
    .


    Organon has become an independent listed company with a broad portfolio of important drugs and products, and is fully prepared to achieve sustainable growth and value


    The goal of Merck’s spin-off is to establish two patient-centric companies, strengthen strategic and operational focus, increase flexibility, simplify operating models, optimize capital structure and improve financial conditions
    .


    Merck believes that the spin-off will bring significant benefits to both Merck and Ogalon, and create value for Merck’s shareholders


    Ogalon does not issue odd shares of ordinary shares in the distribution of shares
    .


    Instead, Merck’s ordinary shareholders received cash to replace the odd shares of Ogalon ordinary shares that they were originally entitled to


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.